611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Stem Cell Therapy Shows Early Promise Against Macular Degeneration1 in 4 Antibiotic Prescriptions Isn't Needed: StudyClimate Change Already Hurting Human Health, Review ShowsGene-Linked Iron Disorder More Common Than ThoughtRace May Matter for Liver Transplant SuccessLife in Space May Take Toll on Spinal MusclesHealth Tip: Understanding a Heart MurmurCalling All Blood Donors …Opioids Now More Deadly for Americans Than Traffic AccidentsWhy Your Heart Needs a Good Night's SleepNature or Nurture? Twins Study Helps Sort Out Genes' Role in DiseaseVaccines: Not Just for KidsExercise Caution to Protect Your Skin at the GymMake Cancer Prevention a Priority in 2019AHA: New Cholesterol Guidelines Put Ethnicity in the SpotlightBroad-Range Ebola Drug Shows Promise in Animal TestsPrescription Opioids May Raise Pneumonia RiskHealth Tip: Prevent Travelers' DiarrheaCancer Patients May Face Greater Risk of ShinglesThyroid Surgery Complications Can Land Some Back in the HospitalRadiation Doses From CT Scans Vary WidelyHealth Tip: Job-Related Chemical Exposure Through the SkinJob Insecurity May Take a Toll on Your HeartPhysical Therapy Can Keep Sports Injuries at BayPersistent Cough May Mean See Your Doctor1 in 10 Adults Have Food Allergies, But Twice as Many Think They DoCatching Up on News About Catch-Up SleepHepatitis C Screening Can Help Prevent Liver DiseaseCan Herbal Drug Kratom Kill?Cholesterol Levels Spike After ChristmasDeadly Meningitis B Targets College StudentsNew Cholesterol Drug's High Price May Not Be Worth It: StudyAsthma Often Goes Undetected in Urban Teens, Study FindsBe Alert for Concussions in Young AthletesHow Seniors Can Prevent Hypothermia This WinterWhopping Numbers on Whooping CoughKidney Disease Risk Tied to Sugar-Sweetened DrinksHealth Tip: Understanding Whooping CoughHealth Tip: Strep Isn't an Ordinary Sore ThroatHolidays' Pitfalls for Those With Food AllergiesWinter's Many Challenges to Eye HealthHeart Risks High in Older Cancer Patients Before DiagnosisCertain Antibiotics Tied to Deadly Heart Vessel Tears: FDAHepatitis C Cases Cluster in States Hit Hard by OpioidsEven Non-Concussion Head Hits Affect Young Football Players' VisionAverage American Getting Fatter, but Not Taller1 in 4 People Over 25 Will Be Hit by StrokeWearing Contacts 24/7 Can Bring Infection, Blindness, Doctors WarnFood Allergies Tied to MS RelapsesRunaway Immune System May Play Role in Chronic Fatigue Syndrome
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Hepatitis C Cases Cluster in States Hit Hard by Opioids

HealthDay News
by By Amy Norton
HealthDay Reporter
Updated: Dec 21st 2018

new article illustration

FRIDAY, Dec. 21, 2018 (HealthDay News) -- More than half of Americans with hepatitis C are living in just nine U.S. states -- five of those in a region hit hard by the opioid epidemic, a new study shows.

The findings offer the latest look at the fallout from the nation's opioid crisis: It's feeding new cases of hepatitis C -- a serious and potentially fatal liver infection.

Overall, "baby boomers" -- Americans born between 1945 and 1965 -- still account for most cases of chronic hepatitis C. But, researchers said, a generation of young Americans is also being put at risk because of opioid abuse.

"A lot of people think hepatitis C is 'over' in this country. But it's not over by a long shot," said Dr. Douglas Dieterich, director of the Institute for Liver Medicine at Mount Sinai Hospital, in New York City.

Dieterich, who was not involved in the study, said the findings are no surprise. Hepatitis C is a blood-borne infection, and most transmissions occur through injecting drugs like heroin, when people share contaminated equipment.

Hepatitis C is a viral infection that causes inflammation in the liver; in most cases, it becomes chronic. Without treatment, about 15 percent to 30 percent of people with chronic hepatitis C will develop cirrhosis (scarring) of the liver, according to the U.S. Centers for Disease Control and Prevention. Smaller numbers develop liver cancer.

The new study is an extension of a CDC report published last month, estimating that over 2 million Americans were living with hepatitis C between 2013 and 2016.

These latest figures show that about 52 percent of those people were living in nine states: California, Texas, Florida, New York, Pennsylvania, Ohio, Michigan, Tennessee and North Carolina.

Five of those states are in the Appalachia region of the country that has a high rate of opioid abuse, the researchers said.

A similar pattern showed up when they looked at the number of hepatitis C cases relative to a state's population. Kentucky, Tennessee and West Virginia were in the top 10 for those rates, and they are three of the states hardest-hit by the opioid epidemic.

The findings were published online Dec. 21 in JAMA Network Open.

According to lead researcher Eli Rosenberg, the data show a picture of two generations: The baby boomers who were infected years ago and continue to live with the liver disease, and the young Americans who are showing an "alarming increase" in new hepatitis C infections due to injection drug abuse.

"Hepatitis C is more common than many people think," said Rosenberg, an associate professor at the State University of New York at Albany School of Public Health. "It's a large epidemic and we have a long way to go toward eradicating it."

Hepatitis C can also be transmitted from pregnant women to their babies. And, Dieterich said, the United States has seen a rise in cases among infants born to mothers who abused injection drugs.

At the same time, recent years have seen a positive development against hepatitis C. New oral drugs with cure rates that top 90 percent after two or three months of treatment.

For decades before that, the only treatment had involved the injection medication interferon -- a year-long regimen that caused flu-like side effects. Even then, the cure rate was only 40 to 50 percent, according to the U.S. Food and Drug Administration.

But, Dieterich said, there are many Americans with hepatitis C who have yet to benefit from the new drugs, such as Sovaldi and Harvoni.

One reason is, many people do not know they have the disease. To help catch those cases, the CDC recommends screening people at increased risk -- including baby boomers and anyone who's ever abused injection drugs.

Then there's the cost. When the new drugs hit the market, they ran as much as $95,000 for a full round of treatment.

State Medicaid programs, which cover many Americans with hepatitis C, balked at the cost and set up restrictions. That generally meant only people with more severe liver damage could get the drugs, Dieterich said.

However, things are shifting, he added -- with a number of Medicaid programs loosening their restrictions.

Ideally, hepatitis C should be prevented, Rosenberg said. He pointed to "syringe service programs" as one measure. The community programs offer injection-drug users clean equipment; some also link people to drug abuse treatment.

However, a CDC study last year found that only three U.S. states have laws that "support full access" to both syringe programs and hepatitis C treatment.

More information

The CDC has more on hepatitis C.